BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3041829)

  • 1. Recombinant interferon alpha-2a for treatment of herpes zoster in immunosuppressed patients with cancer.
    Winston DJ; Eron LJ; Ho M; Pazin G; Kessler H; Pottage JC; Gallagher J; Sartiano G; Ho WG; Champlin RE
    Am J Med; 1988 Aug; 85(2):147-51. PubMed ID: 3041829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of herpes zoster. Recombinant alpha interferon versus acyclovir.
    Duschet P; Schwarz T; Soyer P; Henk A; Hausmaninger H; Gschnait F
    Int J Dermatol; 1988 Apr; 27(3):193-7. PubMed ID: 3286547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of herpes zoster: recombinant alpha-2a-interferon versus acyclovir and vitamin therapy. Clinical Study Group on Interferon.
    Yu B
    Chin Med Sci J; 1993 Mar; 8(1):38-40. PubMed ID: 8274720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prevention of virus infections in immunosuppressed patients.
    Lietman PS; Saral R
    Antiviral Res; 1985; Suppl 1():241-50. PubMed ID: 3002259
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of recombinant alpha-2a interferon in the treatment of herpes zoster].
    Liu Y; Wang J; Li S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):264-6. PubMed ID: 11367689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of interferon and placebo in the treatment of recurrent genital herpes: a double-blind trial.
    Lassus A; Bergelin I; Paloranta A; Rinne E; Eskelinen A; Säilä K
    Sex Transm Dis; 1987; 14(4):185-90. PubMed ID: 3438782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon in skin diseases].
    Niimura M
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):221-6. PubMed ID: 6364993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.
    Merigan TC; Gallagher JG; Pollard RB; Arvin AM
    Antimicrob Agents Chemother; 1981 Jan; 19(1):193-5. PubMed ID: 6166245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte interferon for the treatment of herpes zoster in patients with cancer.
    Merigan TC; Rand KH; Pollard RB; Abdallah PS; Jordan GW; Fried RP
    N Engl J Med; 1978 May; 298(18):981-7. PubMed ID: 347294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Improved clinical course of herpes zoster in immunosuppressed patients treated with fibroblast interferon].
    Heidemann E; Dietz K; Obert HJ; Wilms K
    Onkologie; 1984 Aug; 7(4):210-2. PubMed ID: 6384863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical administration of human leukocyte interferon in patients with herpes zoster].
    Aglić V; Smerdel S; Delimar N; Jusić D; Soos E
    Lijec Vjesn; 1985; 107(11-12):506-10. PubMed ID: 3908864
    [No Abstract]   [Full Text] [Related]  

  • 12. Acyclovir halts progression of herpes zoster in immunocompromised patients.
    Balfour HH; Bean B; Laskin OL; Ambinder RF; Meyers JD; Wade JC; Zaia JA; Aeppli D; Kirk LE; Segreti AC; Keeney RE
    N Engl J Med; 1983 Jun; 308(24):1448-53. PubMed ID: 6343861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Herpes zoster in hematology patients].
    Turkot LA; Donets' IA; Kmita VV
    Lik Sprava; 1993; (2-3):128-31. PubMed ID: 8191711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation.
    Perren TJ; Powles RL; Easton D; Stolle K; Selby PJ
    Am J Med; 1988 Aug; 85(2A):99-101. PubMed ID: 3044103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
    Cunningham AL; Lal H; Kovac M; Chlibek R; Hwang SJ; Díez-Domingo J; Godeaux O; Levin MJ; McElhaney JE; Puig-Barberà J; Vanden Abeele C; Vesikari T; Watanabe D; Zahaf T; Ahonen A; Athan E; Barba-Gomez JF; Campora L; de Looze F; Downey HJ; Ghesquiere W; Gorfinkel I; Korhonen T; Leung E; McNeil SA; Oostvogels L; Rombo L; Smetana J; Weckx L; Yeo W; Heineman TC;
    N Engl J Med; 2016 Sep; 375(11):1019-32. PubMed ID: 27626517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerance of recombinant interferon alfa-2a (Roferon-A) in cancer patients.
    Jones GJ; Itri LM
    Cancer; 1986 Apr; 57(8 Suppl):1709-15. PubMed ID: 3948143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of genital herpes with topically applied interferon.
    Eron LJ; Toy C; Salsitz B; Scheer RR; Wood DL; Nadler PI
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1137-9. PubMed ID: 3310870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.
    Wood MJ; Johnson RW; McKendrick MW; Taylor J; Mandal BK; Crooks J
    N Engl J Med; 1994 Mar; 330(13):896-900. PubMed ID: 8114860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferon.
    Kuhls TL; Sacher J; Pineda E; Santomauro D; Wiesmeier E; Growdon WA; Bryson YJ
    J Infect Dis; 1986 Sep; 154(3):437-42. PubMed ID: 3525695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early vidarabine therapy to control the complications of herpes zoster in immunosuppressed patients.
    Whitley RJ; Soong SJ; Dolin R; Betts R; Linnemann C; Alford CA
    N Engl J Med; 1982 Oct; 307(16):971-5. PubMed ID: 7110300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.